Fig 1.
Flow chart of population of interest extracted from the Western-Normandy MS network database (n = 733).
DMT: Disease Modifying Treatment. SPMS: Secondary Progressive Multiple Sclerosis. RRMS: Relapsing Remitting Multiple Sclerosis.
Table 1.
Characteristics of patients diagnosed with RRMS during the period [1982–2011] in Western-Normandy.
Table 2.
Association between SES and access to a second-line DMT for RRMS patients.
Fig 2.
Influence of SES on delay between first and second line DMT in RRMS patients.
Kaplan-Meier estimates for delay to access a second-line DMT according to EDI quintiles used as SES indicator. A comparison was made between EDI quintile 1 and EDI quintiles 2 to 5 combined. SES: Socio-Economic Status. DMT: Disease Modifying Treatment. RRMS: Relapsing Remitting Multiple Sclerosis. EDI: European Deprivation Index.
Table 3.
Association between SES and access to a second-line DMT for RRMS patients after a 5-years delay between first and second line DMT.